ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BX05 | B | RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation - | 12111 | 53425/1 | ABRYSVO | 1Vial +1Prefilled syringe | Injectable powder + solvent | IM | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 22,650,721 L.L | 19.35 | D | Pfizer Europe MA EEIG | Belgium | 03/06/20 |